Scott M. Rawls - Publications

Temple University, Philadelphia, PA, United States 
Glutamate, cannabinoids, opioids

110 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Foss JD, Nayak SU, Tallarida CS, Farkas DJ, Ward SJ, Rawls SM. Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism. Drug and Alcohol Dependence. 209: 107946. PMID 32145665 DOI: 10.1016/j.drugalcdep.2020.107946  0.32
2020 Eisenstein TK, Chen X, Inan S, Meissler JJ, Tallarida CS, Geller EB, Rawls SM, Cowan A, Adler MW. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management. Military Medicine. 185: 130-135. PMID 32074321 DOI: 10.1093/milmed/usz320  0.84
2019 Nayak SU, Cicalese S, Tallarida C, Oliver CF, Rawls SM. Chemokine CCR5 and cocaine interactions in the brain: cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist. Brain, Behavior, and Immunity. PMID 31557508 DOI: 10.1016/j.bbi.2019.09.017  0.6
2019 Bernstein DL, Nayak SU, Oliver CF, Rawls SM, Rom S. Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates. Neuroscience Research. PMID 31302200 DOI: 10.1016/j.neures.2019.07.003  0.6
2019 Chen X, Cowan A, Inan S, Geller EB, Meissler JJ, Rawls SM, Tallarida RJ, Tallarida CS, Watson MN, Adler MW, Eisenstein TK. Opioid-Sparing Effects of Cannabinoids on Morphine Analgesia: Participation of CB1 and CB2 Receptors. British Journal of Pharmacology. PMID 31218677 DOI: 10.1111/bph.14769  0.84
2019 Saber I, Milewski A, Reitz AB, Rawls SM, Walker EA. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone. Psychopharmacology. PMID 30980094 DOI: 10.1007/s00213-019-05241-z  0.32
2019 Inan S, Watson MN, Doura M, Tallarida CS, Meissler JJ, Chen X, Geller EB, Cowan A, Rawls SM, Eisenstein TK, Adler MW. Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats. British Journal of Anaesthesia. PMID 30916010 DOI: 10.1016/j.bja.2019.01.021  0.84
2019 Gentile TA, Simmons SJ, Tallarida CS, Su S, Rom S, Watson MN, Reitz AB, Potula R, Rawls SM. Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens. Drug and Alcohol Dependence. 197: 22-27. PMID 30754021 DOI: 10.1016/j.drugalcdep.2018.12.022  0.72
2018 Oliver CF, Palamar JJ, Salomone A, Simmons SJ, Philogene-Khalid HL, Stokes-McCloskey N, Rawls SM. Synthetic cathinone adulteration of illegal drugs. Psychopharmacology. PMID 30338489 DOI: 10.1007/s00213-018-5066-6  0.72
2018 Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW. Co-Administration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 30249618 DOI: 10.1124/jpet.118.252890  0.84
2018 Dziedowiec E, Nayak SU, Gruver KS, Jennings T, Tallarida CS, Rawls SM. sMu opioid receptor agonist DAMGO produces place conditioning, abstinence-induced withdrawal, and naltrexone-dependent locomotor activation in planarians. Neuroscience. PMID 29958944 DOI: 10.1016/j.neuroscience.2018.06.029  0.32
2018 Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp J, Rawls SM, Olive MF. Dark Classics in Chemical Neuroscience: "Cathinone-derived Psychostimulants". Acs Chemical Neuroscience. PMID 29714473 DOI: 10.1021/acschemneuro.8b00147  0.72
2018 Hicks C, Huang P, Ramos L, Nayak SU, Caro Y, Reitz AB, Smith GR, Lee DY, Rawls SM, Liu-Chen LY. Dopamine D1-like receptor agonist and D2-like receptor antagonist (-)-Stepholidine reduces reinstatement of drug-seeking behavior for 3,4-methylenedioxypyrovalerone (MDPV) in rats. Acs Chemical Neuroscience. PMID 29597343 DOI: 10.1021/acschemneuro.7b00510  0.52
2018 Oliver CF, Simmons SJ, Nayak SU, Smith GR, Reitz AB, Rawls SM. Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug and Alcohol Dependence. 186: 75-79. PMID 29550625 DOI: 10.1016/j.drugalcdep.2018.01.013  0.72
2017 Zewde AM, Yu F, Nayak S, Tallarida C, Reitz AB, Kirby LG, Rawls SM. PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. Journal of Neuroscience Methods. PMID 29042260 DOI: 10.1016/j.jneumeth.2017.10.010  0.52
2017 Philogene-Khalid HL, Simmons SJ, Nayak S, Martorana RM, Su SH, Caro Y, Ranieri B, DiFurio K, Mo L, Gentile TA, Murad A, Reitz AB, Muschamp JW, Rawls SM. Stereoselective differences between the reinforcing and motivational effects of cathinone-derived 4-methylmethcathinone (mephedrone) in self-administering rats. Acs Chemical Neuroscience. PMID 28885007 DOI: 10.1021/acschemneuro.7b00212  0.72
2017 Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats. Psychopharmacology. PMID 28786030 DOI: 10.1007/s00213-017-4709-3  0.72
2017 Philogene-Khalid HL, Simmons SJ, Muschamp JW, Rawls SM. Effects of ceftriaxone on conditioned nicotine reward in rats. Behavioural Pharmacology. PMID 28704277 DOI: 10.1097/FBP.0000000000000314  0.72
2017 Philogene-Khalid HL, Hicks C, Reitz AB, Liu-Chen LY, Rawls SM. Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats. Drug and Alcohol Dependence. 178: 119-125. PMID 28646714 DOI: 10.1016/j.drugalcdep.2017.04.024  0.72
2017 Hicks C, Gregg RA, Nayak SU, Cannella LA, Schena GJ, Tallarida CS, Reitz AB, Smith GR, Rawls SM. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology. PMID 28251297 DOI: 10.1007/s00213-017-4568-y  0.4
2016 Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, Gentile TA, Watterson LR, Rawls SM, Muschamp JW. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addiction Biology. PMID 27910188 DOI: 10.1111/adb.12479  0.72
2016 Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P, Reitz AB, Smith GR, Rawls SM. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology. PMID 27085607 DOI: 10.1016/j.neuropharm.2016.04.014  1
2016 Nayak S, Roberts A, Bires K, Tallarida CS, Kim E, Wu M, Rawls SM. Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians. Behavioural Pharmacology. PMID 27028903 DOI: 10.1097/FBP.0000000000000236  1
2015 Kim J, John J, Langford D, Walker E, Ward S, Rawls SM. Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice. Amino Acids. PMID 26543027 DOI: 10.1007/s00726-015-2117-8  1
2015 Barr JL, Rasmussen BA, Tallarida CS, Scholl JL, Forster GL, Unterwald EM, Rawls SM. Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat. British Journal of Pharmacology. PMID 26375494 DOI: 10.1111/bph.13330  1
2015 Tallarida CS, Tallarida RJ, Rawls SM. Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats. Drug and Alcohol Dependence. 149: 145-50. PMID 25683823 DOI: 10.1016/j.drugalcdep.2015.01.035  1
2015 Vouga A, Gregg RA, Haidery M, Ramnath A, Al-Hassani HK, Tallarida CS, Grizzanti D, Raffa RB, Smith GR, Reitz AB, Rawls SM. Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates. Neuropharmacology. 91: 109-16. PMID 25496724 DOI: 10.1016/j.neuropharm.2014.11.010  1
2015 Gregg RA, Baumann MH, Partilla JS, Bonano JS, Vouga A, Tallarida CS, Velvadapu V, Smith GR, Peet MM, Reitz AB, Negus SS, Rawls SM. Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. British Journal of Pharmacology. 172: 883-94. PMID 25255824 DOI: 10.1111/bph.12951  1
2014 Tallarida CS, Bires K, Avershal J, Tallarida RJ, Seo S, Rawls SM. Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians. Alcohol (Fayetteville, N.Y.). 48: 579-86. PMID 25212751 DOI: 10.1016/j.alcohol.2014.07.006  1
2014 Schroeder JA, Tolman NG, McKenna FF, Watkins KL, Passeri SM, Hsu AH, Shinn BR, Rawls SM. Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? Drug and Alcohol Dependence. 142: 41-5. PMID 24998018 DOI: 10.1016/j.drugalcdep.2014.05.012  1
2014 Parikh V, Naughton SX, Shi X, Kelley LK, Yegla B, Tallarida CS, Rawls SM, Unterwald EM. Cocaine-induced neuroadaptations in the dorsal striatum: glutamate dynamics and behavioral sensitization. Neurochemistry International. 75: 54-65. PMID 24911954 DOI: 10.1016/j.neuint.2014.05.016  1
2014 Tallarida CS, Egan E, Alejo GD, Raffa R, Tallarida RJ, Rawls SM. Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo. Neuropharmacology. 79: 590-5. PMID 24440755 DOI: 10.1016/j.neuropharm.2014.01.002  1
2014 Gregg RA, Rawls SM. Behavioral pharmacology of designer cathinones: a review of the preclinical literature. Life Sciences. 97: 27-30. PMID 24231450 DOI: 10.1016/j.lfs.2013.10.033  1
2013 Gregg RA, Tallarida CS, Reitz AB, Rawls SM. Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats. Behavioural Pharmacology. 24: 684-8. PMID 24126218 DOI: 10.1097/FBP.0000000000000006  1
2013 Tallarida CS, Corley G, Kovalevich J, Yen W, Langford D, Rawls SM. Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice. Neuroscience Letters. 556: 155-9. PMID 24120434 DOI: 10.1016/j.neulet.2013.09.072  1
2013 Raffa RB, Baron S, Bhandal JS, Brown T, Song K, Tallarida CS, Rawls SM. Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model. Pharmacology, Biochemistry, and Behavior. 112: 9-14. PMID 24084318 DOI: 10.1016/j.pbb.2013.09.012  1
2013 Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM. Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug and Alcohol Dependence. 133: 746-50. PMID 23890492 DOI: 10.1016/j.drugalcdep.2013.06.014  1
2013 Zhang C, Tallarida CS, Raffa RB, Rawls SM. Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians. Physiology & Behavior. 112: 8-13. PMID 23415661 DOI: 10.1016/j.physbeh.2013.02.002  1
2012 Kovalevich J, Corley G, Yen W, Rawls SM, Langford D. Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal. The American Journal of Pathology. 181: 1921-7. PMID 23031254 DOI: 10.1016/j.ajpath.2012.08.013  1
2012 Owaisat S, Raffa RB, Rawls SM. In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism. Neuroscience Letters. 525: 12-6. PMID 22877698 DOI: 10.1016/j.neulet.2012.07.052  1
2012 Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM. Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug and Alcohol Dependence. 126: 257-62. PMID 22652295 DOI: 10.1016/j.drugalcdep.2012.04.021  1
2012 Pagán OR, Baker D, Deats S, Montgomery E, Tenaglia M, Randolph C, Kotturu D, Tallarida C, Bach D, Wilk G, Rawls S, Raffa RB. Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina. The International Journal of Developmental Biology. 56: 193-6. PMID 22451007 DOI: 10.1387/ijdb.113486op  1
2012 Ramoz L, Lodi S, Bhatt P, Reitz AB, Tallarida C, Tallarida RJ, Raffa RB, Rawls SM. Mephedrone ("bath salt") pharmacology: insights from invertebrates. Neuroscience. 208: 79-84. PMID 22300981 DOI: 10.1016/j.neuroscience.2012.01.019  1
2012 Kovalevich J, Corley G, Yen W, Kim J, Rawls SM, Langford D. Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling. Journal of Neurochemistry. 121: 302-13. PMID 22300446 DOI: 10.1111/j.1471-4159.2012.07678.x  1
2012 Tallarida C, Song K, Raffa RB, Rawls SM. Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay. Amino Acids. 42: 2521-4. PMID 21850438 DOI: 10.1007/s00726-011-1052-6  1
2011 Schroeder JA, Quick KF, Landry PM, Rawls SM. Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance. Neuroreport. 22: 970-3. PMID 22027514 DOI: 10.1097/WNR.0b013e32834d87eb  1
2011 Rawls SM, Benamar K. Effects of opioids, cannabinoids, and vanilloids on body temperature. Frontiers in Bioscience (Scholar Edition). 3: 822-45. PMID 21622235  1
2011 Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA, Rawls SM. Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behavioural Pharmacology. 22: 370-3. PMID 21543969 DOI: 10.1097/FBP.0b013e3283473c10  1
2011 Rawls SM, Patil T, Tallarida CS, Baron S, Kim M, Song K, Ward S, Raffa RB. Nicotine behavioral pharmacology: clues from planarians. Drug and Alcohol Dependence. 118: 274-9. PMID 21530106 DOI: 10.1016/j.drugalcdep.2011.04.001  1
2011 Rasmussen B, Unterwald EM, Rawls SM. Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats. Drug and Alcohol Dependence. 118: 484-8. PMID 21524862 DOI: 10.1016/j.drugalcdep.2011.03.022  1
2011 Kim J, Cowan A, Lisek R, Raymondi N, Rosenthal A, Hirsch DD, Rawls SM. Icilin-evoked behavioral stimulation is attenuated by alphaâ‚‚-adrenoceptor activation. Brain Research. 1384: 110-7. PMID 21315691 DOI: 10.1016/j.brainres.2011.02.002  1
2011 Vyas CA, Rawls SM, Raffa RB, Shackman JG. Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. Journal of Pharmacological and Toxicological Methods. 63: 119-22. PMID 20708699 DOI: 10.1016/j.vascn.2010.08.002  1
2011 Rasmussen BA, Baron DA, Kim JK, Unterwald EM, Rawls SM. β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids. 40: 761-4. PMID 20383795 DOI: 10.1007/s00726-010-0589-0  1
2010 Raffa RB, Finno KE, Tallarida CS, Rawls SM. Topiramate-antagonism of L-glutamate-induced paroxysms in planarians. European Journal of Pharmacology. 649: 150-3. PMID 20863783 DOI: 10.1016/j.ejphar.2010.09.021  1
2010 Rawls SM, Shah H, Ayoub G, Raffa RB. 5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians. Neuroscience Letters. 484: 113-7. PMID 20709144 DOI: 10.1016/j.neulet.2010.08.027  1
2010 Rawls SM, Karaca F, Madhani I, Bhojani V, Martinez RL, Abou-Gharbia M, Raffa RB. β-lactamase inhibitors display anti-seizure properties in an invertebrate assay. Neuroscience. 169: 1800-4. PMID 20600649 DOI: 10.1016/j.neuroscience.2010.06.041  1
2010 Rawls SM, Patil T, Yuvasheva E, Raffa RB. First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians. Behavioural Pharmacology. 21: 301-13. PMID 20512030 DOI: 10.1097/FBP.0b013e32833b0098  1
2010 Rawls SM, Baron DA, Kim J. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behavioural Pharmacology. 21: 161-4. PMID 20215965 DOI: 10.1097/FBP.0b013e328337be10  1
2010 Rawls SM, Zielinski M, Patel H, Sacavage S, Baron DA, Patel D. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug and Alcohol Dependence. 107: 261-3. PMID 20004063 DOI: 10.1016/j.drugalcdep.2009.10.010  1
2010 Rasmussen BA, Unterwald EM, Kim JK, Rawls SM. Methanandamide blocks amphetamine-induced behavioral sensitization in rats. European Journal of Pharmacology. 627: 150-5. PMID 19879869 DOI: 10.1016/j.ejphar.2009.10.059  1
2009 Ward SJ, Lefever TW, Rawls SM, Whiteside GT, Walker EA. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. Psychopharmacology. 206: 155-65. PMID 19575185 DOI: 10.1007/s00213-009-1592-6  1
2009 Aggarwal S, Shavalian B, Kim E, Rawls SM. Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. Pharmacology, Biochemistry, and Behavior. 93: 426-32. PMID 19538988 DOI: 10.1016/j.pbb.2009.06.004  1
2009 Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, Rawls SM, Flood P, Hong JS, Lu RB. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2344-57. PMID 19536110 DOI: 10.1038/npp.2009.64  1
2009 Corley G, Rawls SM. Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats. Pharmacology, Biochemistry, and Behavior. 92: 503-7. PMID 19463266 DOI: 10.1016/j.pbb.2009.01.020  1
2009 Rawls SM, Thomas T, Adeola M, Patil T, Raymondi N, Poles A, Loo M, Raffa RB. Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacology, Biochemistry, and Behavior. 93: 363-7. PMID 19447129 DOI: 10.1016/j.pbb.2009.05.005  1
2009 Rasmussen BA, Kim E, Unterwald EM, Rawls SM. Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism. Brain Research. 1260: 7-14. PMID 19401177 DOI: 10.1016/j.brainres.2008.12.078  1
2009 Werkheiser J, Cowan A, Gomez T, Henry C, Parekh S, Chau S, Baron DA, Rawls SM. Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide production. Pharmacology, Biochemistry, and Behavior. 92: 543-8. PMID 19248800 DOI: 10.1016/j.pbb.2009.02.005  1
2008 Rawls SM, Gerber K, Ding Z, Roth C, Raffa RB. Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse (New York, N.Y.). 62: 927-34. PMID 18792993 DOI: 10.1002/syn.20571  1
2008 Rawls SM, Robinson W, Patel S, Baron A. Beta-lactam antibiotic prevents tolerance to the hypothermic effect of a kappa opioid receptor agonist. Neuropharmacology. 55: 865-70. PMID 18644397 DOI: 10.1016/j.neuropharm.2008.06.052  1
2008 Sacavage S, Patel H, Zielinski M, Acker J, Phillips AG, Raffa RB, Rawls SM. Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neuroscience Letters. 439: 84-8. PMID 18511196 DOI: 10.1016/j.neulet.2008.04.086  1
2008 Rawls SM, Baron S, Ding Z, Roth C, Zaveri N, Raffa RB. Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians. Neuropeptides. 42: 229-37. PMID 18479746 DOI: 10.1016/j.npep.2008.03.005  1
2008 Rawls SM, Cavallo F, Capasso A, Ding Z, Raffa RB. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. European Journal of Pharmacology. 584: 278-84. PMID 18342307 DOI: 10.1016/j.ejphar.2008.02.018  1
2008 Raffa RB, Stagliano GW, Ross G, Powell JA, Phillips AG, Ding Z, Rawls SM. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Research. 1193: 51-6. PMID 18178175 DOI: 10.1016/j.brainres.2007.12.001  1
2008 Ding Z, Cowan A, Rawls SM. 5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats. Neuroscience Letters. 430: 191-6. PMID 18155835 DOI: 10.1016/j.neulet.2007.10.033  1
2008 Wang Y, Chen Y, Xu W, Lee DY, Ma Z, Rawls SM, Cowan A, Liu-Chen LY. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A. The Journal of Pharmacology and Experimental Therapeutics. 324: 1073-83. PMID 18089845 DOI: 10.1124/jpet.107.132142  1
2008 Ding Z, Gomez T, Werkheiser JL, Cowan A, Rawls SM. Icilin induces a hyperthermia in rats that is dependent on nitric oxide production and NMDA receptor activation. European Journal of Pharmacology. 578: 201-8. PMID 17976579 DOI: 10.1016/j.ejphar.2007.09.030  1
2007 Rawls SM, Gomez T, Ding Z, Raffa RB. Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5). European Journal of Pharmacology. 575: 103-4. PMID 17765220 DOI: 10.1016/j.ejphar.2007.07.060  1
2007 Rawls SM, Tallarida R, Robinson W, Amin M. The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. British Journal of Pharmacology. 151: 1095-102. PMID 17592517 DOI: 10.1038/sj.bjp.0707309  1
2007 Rawls SM, Schroeder JA, Ding Z, Rodriguez T, Zaveri N. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats. Neuropeptides. 41: 239-47. PMID 17512052 DOI: 10.1016/j.npep.2007.03.001  1
2007 Rawls SM, Amin M, Zisk J. Agmatine blocks morphine-evoked hyperthermia in rats. Brain Research. 1147: 89-94. PMID 17376409 DOI: 10.1016/j.brainres.2006.09.047  1
2007 Rawls SM, Gomez T, Raffa RB. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacology, Biochemistry, and Behavior. 86: 499-504. PMID 17306870 DOI: 10.1016/j.pbb.2007.01.010  1
2007 Werkheiser JL, Rawls SM, Cowan A. Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum. Neuropharmacology. 52: 925-30. PMID 17150231 DOI: 10.1016/j.neuropharm.2006.10.010  1
2007 Rawls SM, Stagliano GW, Gomez T, Raffa RB. Measurement of GABA and glycine in planarians Pharmacologyonline. 1: 1-7.  1
2006 Rawls SM, Tallarida RJ, Zisk J. Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy. European Journal of Pharmacology. 553: 89-98. PMID 17109846 DOI: 10.1016/j.ejphar.2006.08.038  1
2006 Ding Z, Cowan A, Tallarida R, Rawls SM. Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy. Neuroscience Letters. 409: 41-6. PMID 17018247 DOI: 10.1016/j.neulet.2006.09.018  1
2006 Werkheiser JL, Rawls SM, Cowan A. Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats. European Journal of Pharmacology. 547: 101-5. PMID 16945367 DOI: 10.1016/j.ejphar.2006.07.026  1
2006 Rawls SM, Rodriguez T, Baron DA, Raffa RB. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Research. 1099: 82-7. PMID 16782070 DOI: 10.1016/j.brainres.2006.04.103  1
2006 Rawls SM, Ding Z, Cowan A. Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. Pharmacology, Biochemistry, and Behavior. 83: 508-16. PMID 16647109 DOI: 10.1016/j.pbb.2006.03.011  1
2006 Werkheiser JL, Rawls SM, Cowan A. Icilin evokes a dose- and time-dependent increase in glutamate within the dorsal striatum of rats. Amino Acids. 30: 307-9. PMID 16622598 DOI: 10.1007/s00726-005-0306-6  1
2006 Rawls SM, Allebach C, Cowan A. Nitric oxide synthase mediates delta opioid receptor-induced hypothermia in rats. European Journal of Pharmacology. 536: 109-12. PMID 16566919 DOI: 10.1016/j.ejphar.2006.02.044  1
2006 Rawls SM, Cowan A. Modulation of delta opioid-evoked hypothermia in rats by WAY 100635 and fluoxetine. Neuroscience Letters. 398: 319-24. PMID 16483716 DOI: 10.1016/j.neulet.2006.01.017  1
2006 Rawls SM, Gomez T, Stagliano GW, Raffa RB. Measurement of glutamate and aspartate in Planaria. Journal of Pharmacological and Toxicological Methods. 53: 291-5. PMID 16332445 DOI: 10.1016/j.vascn.2005.10.004  1
2006 Rawls SM, Jacobs K, Tallarida RJ. Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. Life Sciences. 78: 669-72. PMID 16137704 DOI: 10.1016/j.lfs.2005.05.056  1
2005 Ding Z, Cowan A, Rawls SM. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors. Brain Research. 1065: 147-51. PMID 16309633 DOI: 10.1016/j.brainres.2005.10.026  1
2005 Rawls SM, Hewson JM, Inan S, Cowan A. Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats. Brain Research. 1049: 61-9. PMID 15936000 DOI: 10.1016/j.brainres.2005.04.074  1
2005 Rawls SM, Ding Z, Gray AM, Cowan A. Peripheral kappa-opioid agonist, ICI 204448, evokes hypothermia in cold-exposed rats. Pharmacology. 74: 79-83. PMID 15687734 DOI: 10.1159/000083704  1
2004 Rawls SM, Baron DA, Gomez T, Jacobs K, Tallarida RJ. Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. European Journal of Pharmacology. 502: 271-2. PMID 15476754 DOI: 10.1016/j.ejphar.2004.08.049  1
2004 Benamar K, Rawls SM, Geller EB, Adler MW. Intrahypothalamic injection of deltorphin-II alters body temperature in rats. Brain Research. 1019: 22-7. PMID 15306234 DOI: 10.1016/j.brainres.2004.05.041  1
2004 Rawls SM, Tallarida RJ, Kon DA, Geller EB, Adler MW. GABAA receptors modulate cannabinoid-evoked hypothermia. Pharmacology, Biochemistry, and Behavior. 78: 83-91. PMID 15159137 DOI: 10.1016/j.pbb.2004.02.006  1
2004 Rawls SM, Tallarida RJ, Gray AM, Geller EB, Adler MW. L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia. The Journal of Pharmacology and Experimental Therapeutics. 308: 780-6. PMID 14610231 DOI: 10.1124/jpet.103.054668  1
2003 Rawls SM, Adler MW, Gaughan JP, Baron A, Geller EB, Cowan A. NMDA receptors modulate morphine-induced hyperthermia. Brain Research. 984: 76-83. PMID 12932841 DOI: 10.1016/S0006-8993(03)03093-2  1
2002 Rawls SM, Cowan A, Tallarida RJ, Geller EB, Adler MW. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia. The Journal of Pharmacology and Experimental Therapeutics. 303: 395-402. PMID 12235276 DOI: 10.1124/jpet.102.037473  1
2002 Rawls SM, Baron DA, Geller EB, Adler MW. Sigma sites mediate DTG-evoked hypothermia in rats. Pharmacology, Biochemistry, and Behavior. 73: 779-86. PMID 12213522 DOI: 10.1016/S0091-3057(02)00903-6  1
2002 Rawls SM, Cabassa J, Geller EB, Adler MW. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. The Journal of Pharmacology and Experimental Therapeutics. 301: 963-8. PMID 12023525 DOI: 10.1124/jpet.301.3.963  1
2000 Rawls SM, McGinty JF. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Research. 861: 296-304. PMID 10760491 DOI: 10.1016/S0006-8993(00)02030-8  1
1999 Gray AM, Rawls SM, Shippenberg TS, McGinty JF. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry. 73: 1066-74. PMID 10461896 DOI: 10.1046/j.1471-4159.1999.0731066.x  1
1999 Rawls SM, McGinty JF, Terrian DM. Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. Journal of Neurochemistry. 73: 1058-65. PMID 10461895 DOI: 10.1046/j.1471-4159.1999.0731058.x  1
1998 Rawls SM, Mcginty JF. Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study. The Journal of Pharmacology and Experimental Therapeutics. 286: 91-8. PMID 9655846  1
1998 Rawls SM, McGinty JF. Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum. Journal of Neurochemistry. 70: 626-34. PMID 9453556  1
1997 Rawls SM, McGinty JF. L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. Journal of Neurochemistry. 68: 1553-63. PMID 9084426  1
Show low-probability matches.